SMAD7 and neoplasm: While previous studies showed that overexpression of the TGFβ signaling inhibitor SMAD7 reduced the proliferation and metastatic potential of the 1205Lu melanoma cell line [65,66], other studies suggested that TGFβ itself could inhibit tumor cell migration and metastasis [12,13].